menu
{ "item_title" : "Hdac/Hat Function Assessment and Inhibitor Development", "item_author" : [" Oliver H. Krämer "], "item_description" : "Part I: In Vivo and 3R Models to Assess HDAC Functions and Effects of HDACi1. Analyzing Lymphoma Development and Progression Using HDACi in Mouse ModelsEva-Maria Piskor, Ren Winkler, and Christian Kosan2. Colony Formation Assay to Test the Impact of HDACi on Leukemic CellsMiriam Pons and Mandy Beyer3. Defined Human Leukemic CD34+ Liquid Cultures to Study HDAC/Transcriptional Repressor ComplexesRoland Windisch, Sophie Kreissig, and Christian Wichmann4. Development of a Cellular Model Mimicking Specific HDAC InhibitorsLena Hess, Verena Moos, and Christian Seiser5. Evaluation of Anti-Tumor and On-Target Activity of HDAC Inhibitors with the Zebrafish Embryo Xenograft ModelCharlotte Gatzweiler, Johannes Ridinger, Simay Ayhan, Sara Najafi, Heike Peterziel, Olaf Witt, and Ina Oehme6. Human Platelet Lysate as Valid Cell Growth Additive to Assess Protein AcetylationMiriam Pons, Roland Conradi, Walburgis Brenner, and Oliver H. Kr mer7. Investigating Physiopathological Roles for Sirtuins in a Mouse ModelShimin Sun, Xiaojiao Xia, Ming Wang, and Baohua Liu8. Patient-Derived Organoids for In Vivo Validation of In Vitro DataSaid Kdimati, Florian B rtin, Michael Linnebacher, and Christina Susanne MullinsPart II: Novel HDAC Inhibitors and Improved Formulations for HDAC Inhibitors9. Analysis of HDACi-Coupled Nanoparticles: Opportunities and ChallengesMarie K hne, Susanne Hofmann, Henry Lindemann, Zolt n Cseresny s, Andreas Dzierza, Daniel Schr der, Maren Godmann, Andreas Koschella, Christian Eggeling, Dagmar Fischer, Marc Thilo Figge, Thomas Heinze, and Thorsten Heinzel10. Development of Pyrazine-Anilinobenzamides as Histone Deacetylase HDAC1-3 Selective Inhibitors and Biological Testing Against Pancreas Cancer Cell LinesMohamed Abdelsalam, Hany S. Ibrahim, Lukas Krauss, Matthes Zessin, Anita Vecchio, Sieglinde Hastreiter, Mike Schutkowski, G nter Schneider, and Wolfgang Sippl11. Evaluation of Small Molecule HDAC Inhibitors through In Vitro and In Cellulo ApproachesNabanita Nawar, Harsimran Kaur Garcha, Abootaleb Sedighi, Elvin D. de Araujo, and Patrick T. Gunning12. Synthesis, Biochemical, and Cellular Evaluation of HDAC6 Targeting Proteolysis Targeting ChimerasSalma Darwish, Tino Heimburg, Johannes Ridinger, Daniel Herp, Matthias Schmidt, Christophe Romier, Manfred Jung, Ina Oehme, and Wolfgang Sippl13. HDACi Delivery Systems Based on Cellulose Valproate NanoparticlesHenry Lindemann, Marie K hne, Andreas Koschella, Maren Godmann, Thorsten Heinzel, and Thomas Heinze", "item_img_path" : "https://covers2.booksamillion.com/covers/bam/1/07/162/787/1071627872_b.jpg", "price_data" : { "retail_price" : "219.99", "online_price" : "219.99", "our_price" : "219.99", "club_price" : "219.99", "savings_pct" : "0", "savings_amt" : "0.00", "club_savings_pct" : "0", "club_savings_amt" : "0.00", "discount_pct" : "10", "store_price" : "" } }
Hdac/Hat Function Assessment and Inhibitor Development|Oliver H. Krämer

Hdac/Hat Function Assessment and Inhibitor Development : Methods and Protocols

local_shippingShip to Me
In Stock.
FREE Shipping for Club Members help

Overview

Part I: In Vivo and 3R Models to Assess HDAC Functions and Effects of HDACi

1. Analyzing Lymphoma Development and Progression Using HDACi in Mouse Models

Eva-Maria Piskor, Ren Winkler, and Christian Kosan

2. Colony Formation Assay to Test the Impact of HDACi on Leukemic Cells

Miriam Pons and Mandy Beyer

3. Defined Human Leukemic CD34+ Liquid Cultures to Study HDAC/Transcriptional Repressor Complexes

Roland Windisch, Sophie Kreissig, and Christian Wichmann

4. Development of a Cellular Model Mimicking Specific HDAC Inhibitors

Lena Hess, Verena Moos, and Christian Seiser

5. Evaluation of Anti-Tumor and On-Target Activity of HDAC Inhibitors with the Zebrafish Embryo Xenograft Model

Charlotte Gatzweiler, Johannes Ridinger, Simay Ayhan, Sara Najafi, Heike Peterziel, Olaf Witt, and Ina Oehme

6. Human Platelet Lysate as Valid Cell Growth Additive to Assess Protein Acetylation

Miriam Pons, Roland Conradi, Walburgis Brenner, and Oliver H. Kr mer

7. Investigating Physiopathological Roles for Sirtuins in a Mouse Model

Shimin Sun, Xiaojiao Xia, Ming Wang, and Baohua Liu

8. Patient-Derived Organoids for In Vivo Validation of In Vitro Data

Said Kdimati, Florian B rtin, Michael Linnebacher, and Christina Susanne Mullins

Part II: Novel HDAC Inhibitors and Improved Formulations for HDAC Inhibitors

9. Analysis of HDACi-Coupled Nanoparticles: Opportunities and Challenges

Marie K hne, Susanne Hofmann, Henry Lindemann, Zolt n Cseresny s, Andreas Dzierza, Daniel Schr der, Maren Godmann, Andreas Koschella, Christian Eggeling, Dagmar Fischer, Marc Thilo Figge, Thomas Heinze, and Thorsten Heinzel

10. Development of Pyrazine-Anilinobenzamides as Histone Deacetylase HDAC1-3 Selective Inhibitors and Biological Testing Against Pancreas Cancer Cell Lines

Mohamed Abdelsalam, Hany S. Ibrahim, Lukas Krauss, Matthes Zessin, Anita Vecchio, Sieglinde Hastreiter, Mike Schutkowski, G nter Schneider, and Wolfgang Sippl

11. Evaluation of Small Molecule HDAC Inhibitors through In Vitro and In Cellulo Approaches

Nabanita Nawar, Harsimran Kaur Garcha, Abootaleb Sedighi, Elvin D. de Araujo, and Patrick T. Gunning

12. Synthesis, Biochemical, and Cellular Evaluation of HDAC6 Targeting Proteolysis Targeting Chimeras

Salma Darwish, Tino Heimburg, Johannes Ridinger, Daniel Herp, Matthias Schmidt, Christophe Romier, Manfred Jung, Ina Oehme, and Wolfgang Sippl

13. HDACi Delivery Systems Based on Cellulose Valproate Nanoparticles

Henry Lindemann, Marie K hne, Andreas Koschella, Maren Godmann, Thorsten Heinzel, and Thomas Heinze

This item is Non-Returnable

Details

  • ISBN-13: 9781071627877
  • ISBN-10: 1071627872
  • Publisher: Humana
  • Publish Date: October 2022
  • Dimensions: 10 x 7 x 1.13 inches
  • Shipping Weight: 2.49 pounds
  • Page Count: 511

Related Categories

You May Also Like...

    1

BAM Customer Reviews